38 results
8-K
EX-99.1
SINT
SINTX Technologies Inc
4 Jan 24
Sintx Technologies Significantly Strengthens Its Antipathogenic Patent Portfolio
7:10am
property that has been created by the SINTX Research and Development team”, said Dr. Ryan Bock, VP of R&D. “Together, these patents showcase a wide … . Over the past several years, SINTX has utilized strategic acquisitions and alliances to enter into new markets. The Company has manufacturing and R&D facilities
8-K
EX-99.1
m3zxdciq0gttqkst51
30 Jun 21
SINTX Technologies Announces the Sale of First Silicon Nitride Antipathogenic Powder to O2TODAY
9:05am
8-K
EX-99.1
ojfhw2c 4f4
22 Jun 20
SINTX Technologies Announces SARS-CoV-2 Testing Results
6:04am